FLKS Flex Pharma, Inc.

3.36
-0.04  -1%
Previous Close 3.40
Open 3.41
Price To book 1.11
Market Cap 57.22M
Shares 17,029,000
Volume 22,104
Short Ratio 6.32
Av. Daily Volume 68,927

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 trial to commence summer of 2017.
FLX-787 - US trial
Amyotrophic lateral sclerosis (ALS)
Phase 2 to be initiated in 2017.
FLX-787
Charcot-Marie-Tooth (CMT)
Phase 2 endpoints not met - October 2016. Announced January 24, 2017 that other indications will take priority over nocturnal leg cramps.
FLX-787
Nocturnal Leg Cramp
Phase 2 data due by the end of 2017.
FLX-787
Multiple Sclerosis
Phase 2 initiated September 2016. Readout due 2017/18.
FLX-787
Amyotrophic lateral sclerosis (ALS)

Latest News

  1. Edited Transcript of FLKS earnings conference call or presentation 3-May-17 12:45pm GMT
  2. Flex Pharma reports 1Q loss
  3. Flex Pharma Reports First Quarter 2017 Financial Results
  4. FDA Clears Flex Pharma's FLX-787 to Commence US Phase 2 Trial in ALS Under IND
  5. Flex Pharma Presents Human Efficacy Data on FLX-787 at the American Academy of Neurology Annual Meeting
  6. Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development
  7. Newly-Published Study Reinforces Efficacy Of HOTSHOT® In Preventing And Treating Muscle Cramps
  8. Edited Transcript of FLKS earnings conference call or presentation 8-Mar-17 1:30pm GMT
  9. Flex Pharma Reports Year End 2016 Financial Results
  10. Flex Pharma to Report Fourth Quarter and Full Year 2016 Results on March 8, 2017
  11. Champion Triathlete Finds Solution For Struggle With Muscle Cramps
  12. Flex Pharma to Present at the BIO CEO & Investor Conference
  13. Flex Pharma Focuses on Phase 2 Clinical Programs in Severe Neurological Diseases
  14. Champion Pro Football Fullback Goes On The Offense Against Game-Changing Cramps
  15. Do Hedge Funds Love Vishay Precision Group Inc (VPG)?
  16. Flex Pharma to Present at the Piper Jaffray 28th Annual Healthcare Conference
  17. Flex Pharma to Present at the Jefferies 2016 Healthcare Conference
  18. Edited Transcript of FLKS earnings conference call or presentation 2-Nov-16 12:45pm GMT